1. Chronic myeloid leukemia: the cutting-edge evidence and things we should know

   • Noriyoshi Iriyama

   Progress in Hematology 08 December 2022 Pages: 1 - 2

2. Guidelines for the treatment of chronic myeloid leukemia from the NCCN and ELN: differences and similarities

   • Zehra Narlı Özdemir
   • Necati Alp Kılıçaslan
   • Ahmet Emre Eşkazan

   Progress in Hematology 05 September 2022 Pages: 3 - 15

3. Asciminib as a third line option in chronic myeloid leukemia

   • Alessandro Laganà
   • Emilia Scalzulli
   • Massimo Breccia

   Progress in Hematology 05 August 2022 Pages: 16 - 23

4. Dose optimization of tyrosine kinase inhibitor therapy in chronic myeloid leukemia

   • Yoshihiro Umezawa
   • Koji Sasaki

   Progress in Hematology 10 September 2022 Pages: 24 - 29

5. Genetic landscape of chronic myeloid leukemia

   • Yotaro Ochi

   Progress in Hematology 07 December 2022 Pages: 30 - 36

   

6. Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series

   • Yoshinobu Kanda
   • Takehiko Mori
   • Kazuma Nishimura

   Rapid Communication Open access 28 November 2022 Pages: 37 - 43

   

7. ORIHIME study: real-world treatment patterns and clinical outcomes of 338 patients with acquired hemophilia A from a Japanese administrative database

   • Yoshiyuki Ogawa
   • Kagehiro Amano
   • Keiji Nogami

   Original Article Open access 04 November 2022 Pages: 44 - 55

   

8. Modified expi293 cell culture system using piggyBac transposon enables efficient production of human FVIII

   • Takuji Yoshimura
   • Kaoru Horiuchi
   • Keiji Nogami

   Original Article 14 October 2022 Pages: 56 - 67

   

9. Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia

   • Naohiro Sekiguchi
   • Senji Kasahara
   • Kensuke Usuki

   Original Article Open access 19 October 2022 Pages: 68 - 77

   

10. Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1

    • Jumpei Ito
    • Kazutsune Yamagata
    • Issay Kitabayashi

    Original Article 24 October 2022 Pages: 78 - 89

    

11. Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease

    • Orly Leiva
    • Siyang Ren
    • Gabriela Hobbs

    Original Article 02 October 2022 Pages: 90 - 99

    

12. Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study

    • Noriko Fukuhara
    • Dai Maruyama
    • Kensei Tobinai

    Original Article Open access 29 September 2022 Pages: 100 - 109

    

13. EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells

    • Kittappa Vinothkumar
    • Sayantan Chanda
    • Soumen Chakraborty

    Original Article 25 October 2022 Pages: 110 - 120

    

14. Short-term efficacy of decitabine-based therapy in JMML: a retrospective study from a single center in China

    • Yuli Cai
    • Jingliao Zhang
    • Xiaofan Zhu

    Original Article 01 October 2022 Pages: 121 - 127

    

15. Impact of muscle loss in children with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation

    • Daisuke Suzuki
    • Ryoji Kobayashi
    • Kunihiko Kobayashi

    Original Article 27 September 2022 Pages: 128 - 133

    

16. Three atypical BCR/ABL transcripts detected simultaneously in a Philadelphia-positive acute lymphoblastic leukemia patient showing resistance to tyrosine kinase inhibitors

    • Haimin Sun
    • Zeying Yan
    • Sujiang Zhang

    Case Report 10 September 2022 Pages: 134 - 136

    

17. Spontaneous regression of dasatinib-related primary effusion lymphoma-like lymphoma

    • Kenta Hayashino
    • Yusuke Meguri
    • Kenji Imajo

    Case Report 06 September 2022 Pages: 137 - 142

    

18. Mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma: a case study

    • Makoto Hirosawa
    • Midori Goto
    • Junichi Tsukada

    Case Report Open access 09 September 2022 Pages: 143 - 148

    

19. Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan

    • Chia-Yu Chen
    • Tzu-Ting Chen
    • Chi-Ching Chen

    Case Report 04 September 2022 Pages: 149 - 152